ACACIA RESEARCH CORP ACTG Income Statement

Acacia research corp (ACTG)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10
Revenues
3,815	-	-	-	3,387	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenues
-	688	1,711	5,460	-	49,203	13,725	6,485	62,093	3,458	-	-	8,854	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenues
-	-	-	-	-	-	-	-	-	-	36,633	16,457	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	66,264	34,939	50,484	99,040	20,795	50,585	39,746	61,130	13,102	63,949	15,006	39,772
Portfolio operations:
Inventor royalties
426	192	776	2,623	1,353	11,002	1,181	1,241	21,744	13	0	4,273	666	3,313	-	-	-	7,756	116	1,265	9,325	4,358	4,667	10,694	951	3,280	2,353	5,610	18,481	3,829	5,032	9,573	7,594	6,458	15,592	8,588	13,089	3,996	14,508	2,877	3,911
Contingent legal fees
234	4	35	375	177	11,756	2,949	1,037	15,759	646	12,173	3,236	627	4,238	-	-	-	3,901	1,972	5,512	4,784	7,296	7,663	7,077	1,527	3,181	2,547	4,024	15,032	5,463	8,833	6,607	3,748	5,547	12,328	13,039	9,367	2,295	9,739	3,465	4,407
Patent acquisition expenses
-	0	0	0	-	0	0	0	4,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Patent acquisition expenses
-	-	-	-	-	-	-	-	-	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Patent acquisition expenses
-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Litigation and licensing expenses - patents
1,037	1,160	987	1,855	3,801	1,689	1,549	2,639	2,989	3,626	4,073	4,134	6,386	5,463	-	-	-	11,341	10,345	9,012	8,675	8,208	9,592	10,820	8,994	8,899	10,870	9,918	9,648	6,969	5,973	5,268	3,381	2,205	3,501	3,761	3,538	2,927	2,835	4,433	3,696
Amortization of patents
1,043	857	863	818	656	11,560	4,952	5,278	5,330	5,443	5,625	5,571	5,515	6,222	-	-	-	13,113	13,688	13,228	13,038	12,796	13,511	15,532	11,906	16,735	12,615	12,578	11,730	18,088	10,412	5,393	5,126	1,427	1,946	2,600	3,772	1,389	1,963	1,876	1,703
Other portfolio expenses (income)
234	-	-	-	-650	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total portfolio expenses
2,506	-	-	-	6,637	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of Goodwill
-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	30,149	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other portfolio expenses
-	1,581	-475	0	-	400	2,202	0	0	1,200	0	-	0	0	-	-	-	250	3,465	0	426	0	1,548	0	0	0	3,506	0	0	-	0	-	-	-	-	-	-	-	-	-	-
Total portfolio expenses
-	3,794	2,186	5,671	-	36,407	12,833	10,195	49,822	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net portfolio income (loss)
1,309	-3,106	-475	-211	-3,250	12,796	892	-3,710	12,271	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Verdict insurance proceeds
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	12,451	0	0	0	0	0	0
Verdict insurance proceeds related costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	7,661	0	0	0	0	0	0
General and administrative expenses
4,878	4,328	4,630	3,763	3,655	2,754	5,855	6,916	3,301	-140	12,715	6,734	7,236	9,056	-	-	-	8,572	9,442	9,587	10,575	12,044	11,636	13,181	11,693	13,988	18,235	13,184	13,844	16,535	11,914	11,903	13,731	8,662	8,748	8,302	9,981	6,291	6,388	6,056	6,332
Research, consulting and other expenses - business development
-	-	-	-	-	-	-	-	-	-	241	433	-	557	-	-	-	860	802	732	997	637	1,208	1,003	992	742	730	726	1,031	721	1,139	1,967	1,116	1,445	850	1,335	708	835	461	453	372
Impairment of Intangible Assets (Excluding Goodwill)
-	-	-	-	-	-	-	-	-	-	2,248	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of patent-related intangible assets
-	0	0	0	-	0	0	28,210	0	0	-	-	0	2,175	-	-	-	74,731	0	0	0	931	0	0	2,566	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net portfolio income (loss)
1,309	-3,106	-475	-211	-3,250	12,796	892	-3,710	12,271	-7,470	-	-	-4,340	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating costs and expenses
-	-	-	-	-	-	-	-	-	-	37,075	24,381	-	31,024	-	-	-	150,673	39,830	39,336	47,820	46,270	49,825	58,307	38,629	46,825	50,856	46,040	69,766	51,605	43,303	40,711	34,696	25,744	38,175	37,625	40,455	17,733	35,894	19,160	20,421
Operating loss
-3,569	-7,434	-5,105	-3,974	-6,905	10,042	-4,963	-38,836	8,970	-7,330	-442	-7,924	-11,576	-9,055	-	-	-	-113,176	-26,836	1,000	-13,610	-15,240	-12,633	-8,231	-26,051	-31,760	-35,336	-22,930	7,095	14,659	-8,364	9,773	64,344	-4,949	12,410	2,121	20,675	-4,631	28,055	-4,154	19,351
Other income (expense):
Gain on Conversion of Loan and Accrued Interest
-	-	-	-	-	-	-	-	-	-	0	2,671	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on exercise of Primary Warrant
-	-	-	-	-	-	-	-	-	-	0	-4,616	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of investment, net (Note 5)
4,108	277	-4,266	6,980	6,908	-	-	-	-	-	158,979	-12,698	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on sale of investment (Note 5)
3,316	1,083	915	1,642	5,590	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of the Series A and B warrants and embedded derivative
-4,382	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of trading securities
-6,117	-	-	-	675	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain (loss) on sale of trading securities
112	-	-	-	-43	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income (Loss) from Equity Method Investments
-	-	-	-	-	-	-	-	-	-	-116	-14	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investment Income, Interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	205	121	100	56	-	-	-	-	-	-	-	-
Write off of investment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	45	-	-	-	-	-	-	-	-	-	-
Interest income and other
-	-	-	-	-	-	-	-	-	-102,950	164	563	696	592	-	-	-	0	-180	-104	228	-451	-57	-196	109	161	280	400	1,290	-	-	102	56	-	-	-	-	-	-	-	-
Interest income and other
535	2,082	718	1,802	871	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net realized gain (loss) on investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-117	2	0	-	-	-	-	-	-	-	-
Total other income (expense)
-9,060	5,921	-2,503	-1,774	2,821	-21,012	-27,595	10,615	-40,890	-	159,027	-4,862	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-41	-	-	-	-	-	-	-	-	-	-
Interest and investment income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	52	44	20	19
Loss before income taxes
-12,629	-1,513	-7,608	-5,748	-4,084	-10,970	-32,558	-28,221	-31,920	-110,280	158,585	-12,786	-10,880	-8,463	-	-	-	-113,176	-27,016	896	-13,382	-15,691	-12,690	-8,427	-25,942	-31,599	-35,056	-22,530	8,385	15,479	-8,405	9,875	64,400	-4,931	12,435	2,145	20,704	-4,579	28,099	-4,134	19,370
Income tax benefit (expense)
-1,338	-2,147	0	9	314	397	306	285	191	20	216	1,478	1,241	2,414	-	-	-	4,174	337	119	170	450	145	4,689	-1,372	3,390	-19,570	-9,050	3,272	5,757	-1,938	3,494	14,747	-635	1,889	306	7,148	1,115	317	-13	321
Net loss including noncontrolling interests in subsidiaries
-11,291	634	-7,608	-5,757	-4,398	-11,367	-32,864	-28,506	-32,111	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Business Acquisition, Pro Forma Provision for Income Taxes
-1,338	-2,147	0	9	314	397	306	285	191	20	216	1,478	1,241	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,115	317	-13	321
Net loss including noncontrolling interests in subsidiaries
-	-	-	-	-	-	-	-	-	-110,300	158,369	-14,264	-12,121	-10,877	-	-	-	-117,350	-27,353	777	-13,552	-16,141	-12,835	-13,116	-24,570	-34,989	-15,486	-13,480	5,113	9,722	-6,467	6,381	49,653	-4,296	10,546	1,839	13,556	-5,694	27,782	-4,121	19,049
Net (income) loss attributable to noncontrolling interests in subsidiaries
0	0	0	0	-14	2	331	-79	-73	-97	-96	-12	-291	-266	-	-	-	-1,440	-43	4,463	-422	103	-420	-167	-149	-1,656	225	-977	0	-101	152	60	-275	-107	-257	-300	1,203	-424	3,107	-255	537
Business Acquisition, Pro Forma Net (Income) Loss Attributable to Noncontrolling Interests
0	0	0	0	-14	2	331	-79	-73	-97	-96	-12	-291	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-424	3,107	-255	537
Net loss attributable to Acacia Research Corporation
-11,291	634	-7,608	-5,757	-4,384	-11,369	-33,195	-28,427	-32,038	-110,203	158,465	-14,252	-11,830	-10,611	-	-	-	-115,910	-27,310	-3,686	-13,130	-16,244	-12,415	-12,949	-24,421	-33,333	-15,711	-12,503	5,113	9,823	-6,619	6,321	49,928	-4,189	10,803	2,139	12,353	-5,270	24,675	-3,866	18,512
Less: Dividend on Series A redeemable convertible preferred stock
263	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Accretion of Series A redeemable convertible preferred stock
631	307	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to common stockholders - basic and diluted
-12,185	327	-7,608	-5,757	-4,384	-11,369	-33,195	-28,427	-32,038	-	158,326	-14,252	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-6,619	-	-	-	-	-	-	-	-	-	-
Basic net loss per share of common stock
-	0.01	-0.15	-0.12	-	-0.23	-0.67	-0.57	-0.63	-	3.13	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.69	-0.33	-0.26	0.10	0.20	-0.14	0.13	1.13	-0.10	0.26	0.05	0.35	-0.16	0.75	-0.12	0.60
Weighted average number of shares outstanding - basic
-	49,875	49,828	49,696	-	49,639	49,557	50,061	50,632	-	50,554	-	-	-	-	-	-	-	-	-	-	-	-	-	-	48,415	48,330	48,008	47,859	48,335	48,332	47,944	44,367	41,418	41,292	40,994	35,182	33,879	32,794	31,664	30,847
Less: Accretion of redeemable preferred stock
631	307	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Mark-to-market adjustment for preferred stock embedded derivative
-	-3,258	0	0	-	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic and diluted net loss per common share
-0.24	-	-0.16	-0.11	-0.09	-	-	-	-	-2.18	-	-0.28	-0.24	-0.21	-	-	-	-2.33	-0.55	-0.08	-0.27	-0.34	-0.26	-0.27	-0.51	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to common stockholders - diluted
-	-2,624	-7,608	-5,757	-	-11,369	-33,195	-28,427	-32,038	-	158,326	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-6,619	-	-	-	-	-	-	-	-	-	-
Diluted net loss per share of common stock
-	-0.05	-0.15	-0.12	-	-0.23	-0.67	-0.57	-0.63	-	3.13	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.69	-0.33	-0.26	0.10	0.20	-0.14	0.13	1.09	-0.10	0.25	0.05	0.34	-0.16	0.70	-0.12	0.55
Weighted average number of shares outstanding - diluted
-	54,406	49,828	49,696	-	49,639	49,557	50,061	50,632	50,590	50,599	-	50,333	-	-	-	-	-	-	-	-	-	-	-	-	48,415	48,330	48,008	48,104	48,797	48,641	48,938	45,771	41,418	42,857	42,453	36,448	33,879	35,105	31,664	33,411
Weighted average number of shares outstanding - basic and diluted
49,875	-	49,830	49,696	49,655	-	-	-	-	-	-	50,499	-	50,237	-	-	-	49,749	49,630	49,423	49,212	48,944	48,806	48,543	48,329	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and administrative expenses(1)
4,878	4,328	4,630	3,763	3,655	2,754	5,855	6,916	3,301	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and administrative expenses excluding share-based compensation
-	-	-	-	-	-	-	-	-	-	3,262	5,247	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash stock compensation general and administrative
-	-	-	-	-	-	-	-	-	-	1,272	1,449	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash stock compensation - profits interests
-	-	-	-	-	-	-	-	-	-	8,181	38	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash stock compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,544	1,475	1,735	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-